Therapeutic Asset Ratings
502 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
(+)-VINCRISTINE
Breast
AstraZeneca
P1/2
CCC
(48)
Zirconium Zr 89 Crefmirlimab Berdoxam
Urinary Bladder Neoplasm
AstraZeneca
P1/2
CCC
(48)
[14C]AZD9833
Breast Carcinoma
AstraZeneca
P1
CC
(47)
azd2693
Liver Disorder
AstraZeneca
P1
CC
(47)
azd7503
Fatty Liver, Nonalcoholic
AstraZeneca
P1
CC
(47)
CAFFEINE
Liver Disorder
AstraZeneca
P1
CC
(47)
Camizestrant
ER-positive, HER2-negative Breast Cancer
AstraZeneca
P1
CC
(47)
Camizestrant
Liver Disorder
AstraZeneca
P1
CC
(47)
Eplontersen
Familial Visceral Amyloidosis
AstraZeneca
P1
CC
(47)
MIDAZOLAM
Liver Disorder
AstraZeneca
P1
CC
(47)
(+)-QUINIDINE
Liver Disorder
AstraZeneca
P1
CC
(47)
Wellbutrin
Advanced Chronic Liver Disease
AstraZeneca
P1
CC
(47)
1H-BENZIMIDAZOLE, 2-(((4-(3-METHOXYPROPOXY)-3-METHYL-2-PYRIDINYL)METHYL)SULFINYL)-, SODIUM SALT, HYDRATE (1:1:1)
Lung Squamous Cell Carcinoma
AstraZeneca
P1/2
CC
(47)
azd3632
Adult Acute Lymphoblastic Leukemia
AstraZeneca
P1/2
CC
(47)
azd5305
Squamous Cell Lung Carcinoma
AstraZeneca
P1/2
CC
(47)
azd7789
Gastroesophageal Junction Adenocarcinoma
AstraZeneca
P1/2
CC
(47)
Palacaparib
Squamous Cell Lung Carcinoma
AstraZeneca
P1/2
CC
(47)
Posaconazole
Adult Acute Lymphoblastic Leukemia
AstraZeneca
P1/2
CC
(47)
Surovatamig
B-Cell Chronic Lymphocytic Leukemia
AstraZeneca
P1/2
CC
(47)
Torvutatug Samrotecan
Squamous Cell Lung Carcinoma
AstraZeneca
P1/2
CC
(47)
(+)-VINCRISTINE
B-Cell Chronic Lymphocytic Leukemia
AstraZeneca
P1/2
CC
(47)
gamma1 heavy chain humanized (1-448) [VH (Homo sapiens IGHV3-15*07 (86.9%)--(IGHD) -IGHJ1*01(90.9%), CDR-IMGT [8.10.9] (26-33.51-60.99-107))(1-118) -Homo sapiens IGHG1*01 (100%), G1m17,1 CH1K120, CH3 D12, L14 (CH1 K120 (215) (119-216),hinge 1-15 (217-231), CH2 (232-341), CH3 D12 (357), L14 (359) (342-446), CHS (447-448)) (119-448)], (221-220')-disulfide with kappa light chain humanized (1'-220') [V-KAPPA (Homo sapiens IGKV2-24*01 (90.0%)-IGKJ2*01 (100%), CDR-IMGT [11.3.10] (27-37.55-57.94-103)) (1'-113') -Homo sapiens IGKC*01 (100%), Km3, A45.1 (159), V101 (197) (114'-220')]; dimer (227-227'':230-230'')-bisdisulfide, produced in Chinese hamster ovary (CHO) cells, derived from the cell line CHO-K1, glycoform alfa
Non-Small Cell Lung Carcinoma
AstraZeneca
P2
CC
(46)
Rilvegostomig
Colorectal Cancer
AstraZeneca
P2
CC
(46)
Trastuzumab Deruxtecan
Prostate Cancer
AstraZeneca
P2
CC
(46)
Volrustomig
Colorectal Cancer
AstraZeneca
P2
CC
(46)
Showing 226 to 250 of 502 assets
Previous
Page 10 of 21
Next
